Brakenhoff RH - Search Results

1

Dissecting the metastatic cascade.

Pantel K, Brakenhoff RH. Pantel K, et al. Among authors: brakenhoff rh. Nat Rev Cancer. 2004 Jun;4(6):448-56. doi: 10.1038/nrc1370. Nat Rev Cancer. 2004. PMID: 15170447 Review. No abstract available.

2

Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.

Wrage M, Ruosaari S, Eijk PP, Kaifi JT, Hollmén J, Yekebas EF, Izbicki JR, Brakenhoff RH, Streichert T, Riethdorf S, Glatzel M, Ylstra B, Pantel K, Wikman H. Wrage M, et al. Among authors: brakenhoff rh. Clin Cancer Res. 2009 Mar 1;15(5):1566-74. doi: 10.1158/1078-0432.CCR-08-2188. Epub 2009 Feb 10. Clin Cancer Res. 2009. PMID: 19208797

3

Detection, clinical relevance and specific biological properties of disseminating tumour cells.

Pantel K, Brakenhoff RH, Brandt B. Pantel K, et al. Among authors: brakenhoff rh. Nat Rev Cancer. 2008 May;8(5):329-40. doi: 10.1038/nrc2375. Nat Rev Cancer. 2008. PMID: 18404148 Review.

4

Molecular signature associated with bone marrow micrometastasis in human breast cancer.

Woelfle U, Cloos J, Sauter G, Riethdorf L, Jänicke F, van Diest P, Brakenhoff R, Pantel K. Woelfle U, et al. Cancer Res. 2003 Sep 15;63(18):5679-84. Cancer Res. 2003. PMID: 14522883

5

Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer.

Woelfle U, Sauter G, Santjer S, Brakenhoff R, Pantel K. Woelfle U, et al. Clin Cancer Res. 2004 Apr 15;10(8):2670-4. doi: 10.1158/1078-0432.ccr-03-0114. Clin Cancer Res. 2004. PMID: 15102669

6

Microarray analysis of bleomycin-exposed lymphoblastoid cells for identifying cancer susceptibility genes.

Cloos J, de Boer WP, Snel MH, van den Ijssel P, Ylstra B, Leemans CR, Brakenhoff RH, Braakhuis BJ. Cloos J, et al. Among authors: brakenhoff rh. Mol Cancer Res. 2006 Feb;4(2):71-7. doi: 10.1158/1541-7786.MCR-05-0196. Mol Cancer Res. 2006. PMID: 16513838

7

Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma.

de Nooij-van Dalen AG, van Dongen GA, Smeets SJ, Nieuwenhuis EJ, Stigter-van Walsum M, Snow GB, Brakenhoff RH. de Nooij-van Dalen AG, et al. Among authors: brakenhoff rh. Int J Cancer. 2003 Mar 1;103(6):768-74. doi: 10.1002/ijc.10903. Int J Cancer. 2003. PMID: 12516096

8

The molecular landscape of head and neck cancer.

Leemans CR, Snijders PJF, Brakenhoff RH. Leemans CR, et al. Among authors: brakenhoff rh. Nat Rev Cancer. 2018 May;18(5):269-282. doi: 10.1038/nrc.2018.11. Epub 2018 Mar 2. Nat Rev Cancer. 2018. PMID: 29497144 Review.

9

The molecular biology of head and neck cancer.

Leemans CR, Braakhuis BJ, Brakenhoff RH. Leemans CR, et al. Among authors: brakenhoff rh. Nat Rev Cancer. 2011 Jan;11(1):9-22. doi: 10.1038/nrc2982. Epub 2010 Dec 16. Nat Rev Cancer. 2011. PMID: 21160525 Review.

10

Differential diagnosis of pulmonary carcinoma following head and neck cancer by genetic analysis.

Geurts TW, van Velthuysen ML, Broekman F, van Huysduynen TH, van den Brekel MW, van Zandwijk N, van Tinteren H, Nederlof P, Balm AJ, Brakenhoff RH. Geurts TW, et al. Among authors: brakenhoff rh. Clin Cancer Res. 2009 Feb 1;15(3):980-5. doi: 10.1158/1078-0432.CCR-08-1968. Clin Cancer Res. 2009. PMID: 19188169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results